[Retracted] Targeting AraC-Resistant Acute Myeloid Leukemia by Dual Inhibition of CDK9 and Bcl-2: A Systematic Review and Meta-Analysis

Figure 1

In araC-resistant AML, we apply AZD4573 and 10058F4 to downregulate c-Myc to inhibit Bcl-2 and affect the cell proliferation, cell cycle and apoptosis, and cell autophagy.